Alto Neuroscience | 10-Q: Quarterly report
Alto Neuroscience | 8-K: Alto Neuroscience Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Alto Neuroscience | 8-K: Current report
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Savitz Adam
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Hanley Jr. Michael Conick
Alto Neuroscience | 3: Initial statement of beneficial ownership of securities-Officer Hanley Jr. Michael Conick
Alto Neuroscience | 8-K: Current report
Alto Neuroscience | 10-Q: Quarterly report
Alto Neuroscience | 8-K: Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Smith Nicholas Conrad
Alto Neuroscience | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.2%),Peter Kolchinsky(5.2%), etc.
Alto Neuroscience | 10-K: FY2023 Annual Report
Alto Neuroscience | 8-K: Current report
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Radhakrishnan Maha
Alto Neuroscience | 3: Initial statement of beneficial ownership of securities-Director Radhakrishnan Maha
Alto Neuroscience | 8-K: Current report
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities- Apeiron Investment Group Ltd.
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Savitz Adam
Alto Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Etkin Amit
Alto Neuroscience | SC 13G: Statement of acquisition of beneficial ownership by individuals-Alpha Wave Global, LP(13.8%),Alpha Wave Ventures GP, Ltd(13.8%), etc.
No Data
No Data